NO177228C - Fremgangsmåte for fremstilling av ciclosporin i ortorombisk krystallform - Google Patents

Fremgangsmåte for fremstilling av ciclosporin i ortorombisk krystallform

Info

Publication number
NO177228C
NO177228C NO885625A NO885625A NO177228C NO 177228 C NO177228 C NO 177228C NO 885625 A NO885625 A NO 885625A NO 885625 A NO885625 A NO 885625A NO 177228 C NO177228 C NO 177228C
Authority
NO
Norway
Prior art keywords
ciclosporin
preparation
crystal form
orthorhombic crystal
orthorhombic
Prior art date
Application number
NO885625A
Other languages
English (en)
Norwegian (no)
Other versions
NO885625D0 (no
NO885625L (no
NO177228B (no
Inventor
Danielle Giron
Martin List
Friedrich Richter
Yasuyuki Uike
Hans Peter Weber
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NO885625D0 publication Critical patent/NO885625D0/no
Publication of NO885625L publication Critical patent/NO885625L/no
Publication of NO177228B publication Critical patent/NO177228B/no
Publication of NO177228C publication Critical patent/NO177228C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64Cyclic peptides containing only normal peptide links
    • C07K7/645Cyclosporins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1688Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
NO885625A 1987-12-21 1988-12-19 Fremgangsmåte for fremstilling av ciclosporin i ortorombisk krystallform NO177228C (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13623087A 1987-12-21 1987-12-21
US17261388A 1988-03-24 1988-03-24
US21254888A 1988-06-28 1988-06-28

Publications (4)

Publication Number Publication Date
NO885625D0 NO885625D0 (no) 1988-12-19
NO885625L NO885625L (no) 1989-06-22
NO177228B NO177228B (no) 1995-05-02
NO177228C true NO177228C (no) 1995-08-09

Family

ID=27384838

Family Applications (1)

Application Number Title Priority Date Filing Date
NO885625A NO177228C (no) 1987-12-21 1988-12-19 Fremgangsmåte for fremstilling av ciclosporin i ortorombisk krystallform

Country Status (27)

Country Link
JP (1) JPH0791316B2 (fr)
KR (1) KR100188305B1 (fr)
AT (1) AT403163B (fr)
AU (1) AU626274B2 (fr)
BE (1) BE1002665A4 (fr)
CA (1) CA1341396C (fr)
CH (1) CH677926A5 (fr)
CY (1) CY1799A (fr)
DE (1) DE3843054C2 (fr)
DK (1) DK175220B1 (fr)
ES (1) ES2012580A6 (fr)
FI (1) FI89065C (fr)
FR (1) FR2624863B1 (fr)
GB (1) GB2211848B (fr)
GR (1) GR1002486B (fr)
HK (1) HK102894A (fr)
HU (1) HU203564B (fr)
IE (1) IE62006B1 (fr)
IL (1) IL88719A0 (fr)
IT (1) IT1235356B (fr)
LU (1) LU87409A1 (fr)
MY (1) MY103943A (fr)
NL (1) NL195096C (fr)
NO (1) NO177228C (fr)
NZ (1) NZ227384A (fr)
SE (1) SE503174C2 (fr)
SG (1) SG99494G (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639724A (en) 1984-07-24 1997-06-17 Sandoz Ltd. Cyclosporin galenic forms
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
US7081445B2 (en) 1989-02-20 2006-07-25 Novartis Ag Cyclosporin galenic forms
US5294604A (en) * 1989-12-20 1994-03-15 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Method of treating ocular diseases by periocular administration of cyclosporine A or G
GB9105705D0 (en) * 1991-03-18 1991-05-01 Sandoz Ltd Improvements in or relating to organic compounds
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
SG45449A1 (en) * 1992-05-13 1998-01-16 Sandoz Ltd Ophthalmic compositions
DK0589843T3 (da) 1992-09-25 2002-04-02 Novartis Ag Cyclosporinholdige farmaceutiske præparater
JP3833248B2 (ja) 1994-11-03 2006-10-11 ノバルティス・アクチエンゲゼルシャフト 簡単な組成及び高い生物有効性を有する経口投与のためのシクロスポリンの新規処方物及びその製造法
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
US5766629A (en) 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
DE19544507B4 (de) 1995-11-29 2007-11-15 Novartis Ag Cyclosporin enthaltende Präparate
US6262054B1 (en) 1996-02-01 2001-07-17 Sloan-Kettering Institute Of Cancer Research Combination therapy method for treating breast cancer using edatrexate
AU737053B2 (en) 1997-01-30 2001-08-09 Novartis Ag Oil-free pharmaceutical compositions containing cyclosporin A
TW581681B (en) 1998-02-20 2004-04-01 Nektar Therapeutics Liquid crystal forms of cyclosporin
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
CA2553381C (fr) 2004-01-20 2011-03-22 Allergan, Inc. Compositions pour traitement local de l'oeil, comprenant de preference de l'acetonide de triamcinolone et de l'acide hyaluronique
CN1763084B (zh) * 2005-10-11 2010-04-21 山东新时代药业有限公司 高纯度环孢菌素a的制备方法
MY180581A (en) 2011-05-27 2020-12-02 Allergan Inc A crystalline form of cyclosporine a, methods of preparation, and methods for use thereof
CN104080442B (zh) * 2011-11-15 2018-01-05 阿勒根公司 环孢菌素a形式2的悬浮液
AU2012339701B8 (en) * 2011-11-15 2017-11-16 Allergan, Inc. Autoclavable suspensions of cyclosporin A Form 2
RU2639393C2 (ru) 2011-11-15 2017-12-21 Аллерган, Инк. Состав пролонгированного действия циклоспорина формы 2
EP2780358B1 (fr) * 2011-11-15 2016-03-23 Allergan, Inc. Forme 2 de la cyclosporine et procédé pour sa préparation
TW202430537A (zh) * 2022-10-20 2024-08-01 日商中外製藥股份有限公司 環狀胜肽的結晶的製造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH614931A5 (fr) * 1975-11-04 1979-12-28 Sandoz Ag
CH640519A5 (en) * 1976-04-09 1984-01-13 Sandoz Ag Process for preparing a modified form of the antibiotic S 7481/F-1
US4117118A (en) * 1976-04-09 1978-09-26 Sandoz Ltd. Organic compounds
DE2819094A1 (de) * 1977-05-10 1978-11-23 Sandoz Ag Cyclosporin-derivate, ihre verwendung und herstellung
CH637124A5 (en) * 1978-10-18 1983-07-15 Sandoz Ag Antibiotic, its preparation and use

Also Published As

Publication number Publication date
AT403163B (de) 1997-11-25
KR100188305B1 (ko) 1999-06-01
FI89065C (fi) 1993-09-30
FI885869L (fi) 1989-06-22
FI89065B (fi) 1993-04-30
MY103943A (en) 1993-10-30
GB8829556D0 (en) 1989-02-08
IT8848690A0 (it) 1988-12-20
DK705488D0 (da) 1988-12-19
SG99494G (en) 1994-10-28
IE62006B1 (en) 1994-12-14
DE3843054C2 (de) 2003-08-21
CY1799A (en) 1995-02-17
HK102894A (en) 1994-09-30
BE1002665A4 (fr) 1991-04-30
KR890009975A (ko) 1989-08-05
ES2012580A6 (es) 1990-04-01
NZ227384A (en) 1991-09-25
CA1341396C (fr) 2002-11-05
SE8804570D0 (sv) 1988-12-19
IL88719A0 (en) 1989-07-31
JPH01211598A (ja) 1989-08-24
GR1002486B (el) 1996-12-09
DK175220B1 (da) 2004-07-12
SE503174C2 (sv) 1996-04-15
CH677926A5 (fr) 1991-07-15
GB2211848B (en) 1991-11-06
JPH0791316B2 (ja) 1995-10-04
GR880100850A (el) 1994-03-31
AU2705588A (en) 1989-06-22
FR2624863B1 (fr) 1991-04-26
FI885869A0 (fi) 1988-12-19
DE3843054A1 (de) 1989-07-27
NO885625D0 (no) 1988-12-19
AU626274B2 (en) 1992-07-30
NL8803125A (nl) 1989-07-17
LU87409A1 (fr) 1989-07-07
DK705488A (da) 1989-06-22
FR2624863A1 (fr) 1989-06-23
NL195096C (nl) 2004-02-09
IE883779L (en) 1989-06-21
HU203564B (en) 1991-08-28
HUT49893A (en) 1989-11-28
NO885625L (no) 1989-06-22
SE8804570L (sv) 1989-06-22
ATA309588A (de) 1997-04-15
GB2211848A (en) 1989-07-12
IT1235356B (it) 1992-06-30
NO177228B (no) 1995-05-02

Similar Documents

Publication Publication Date Title
NO177228C (no) Fremgangsmåte for fremstilling av ciclosporin i ortorombisk krystallform
FI875660L (fi) Menetelmä terapeuttisesti käyttökelpoisten 5-fenyyli-2-pyrimidinonijohdannaisten valmistamiseksi
FI881900A7 (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten substituoitujen imidatsolyylialkyylipiperatsiini- ja -diatsepiinijohdannaisten valmistamiseksi
HK10192A (en) Derivatives of acrylic acid useful in agriculture
NO174395C (no) Flytende rensemiddelblanding og fremgangsmåte for fremstilling av denne
NO178619C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive di-t-butylfenoler
HUT51848A (en) Process for conservation of transpantable epitheliumshives produced in vitro
FI874459A7 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten piperidiinijohdannaisten valmistamiseksi
FI891074A0 (fi) Menetelmä syklisten sulfaattien valmistamiseksi
BR8803422A (pt) Processo de preparacao de copolimeros em blocos
FI895417A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 2'-halometylideeninukleosidien valmistamiseksi
EP0242686A3 (en) Process for the preparation of d-(+)-biotine
GB2219725B (en) Improvements in or relating to the manufacture of lollipops
GB8607482D0 (en) Orientation of crystals
GB2189485B (en) Derivatives of acrylic acid useful in agriculture
TR23485A (tr) Fermentasyon proseslerinin aktivasyonu icin bilesim ve dogal ueruenlerin fermentasyon derecelerindeki azalmayi hizlandirmak icin proses
EP0295859A3 (en) Production of proteins in active forms
GB8717640D0 (en) Preparation of esters
DK390288D0 (da) Forbedringer i og vedroerende hybridfroeproduktion
EG18596A (en) Process for the preparation of peptide structure and immunogens containing them useful in the control of fertility
PT84184A (pt) Process for the preparation of 8 alpha-acylaminoergolines and of pharmaceutical compositions containing them
NO174085C (no) Fremgangsmåte for fremstilling av sukralfatpreparater
AU2810089A (en) Production of proteins in plants
EP0242315A3 (en) Proceeding to thermosphape soles of several colours in ethyl-vinyl acetate
NO176763C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive azepinonderivater